{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T07:22:52Z","timestamp":1769844172206,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.mehy.2018.12.005","type":"journal-article","created":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T17:12:15Z","timestamp":1544202735000},"page":"9-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Adiponectin: A potential candidate for treating fibrosis in posterior segment of the eye"],"prefix":"10.1016","volume":"123","author":[{"given":"Karthikka","family":"Palanisamy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajiv","family":"Raman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konerirajapuram Natarajan","family":"Sulochana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subbulakshmi","family":"Chidambaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2018.12.005_b0005","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1172\/JCI31487","article-title":"Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases","volume":"117","author":"Wynn","year":"2007","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.mehy.2018.12.005_b0010","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/j.mehy.2018.12.005_b0015","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMra1300575","article-title":"Fibrosis \u2014 a common pathway to organ injury and failure","volume":"372","author":"Rockey","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2018.12.005_b0020","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1172\/JCI31030","article-title":"Fibrosis and diseases of the eye","volume":"117","author":"Friedlander","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2018.12.005_b0025","first-page":"257","article-title":"Regeneration and fibrosis of corneal tissues","volume":"45","author":"Simirskii","year":"2014","journal-title":"Ontogenez"},{"key":"10.1016\/j.mehy.2018.12.005_b0030","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1080\/15384101.2016.1170261","article-title":"Pro-fi brotic pathway activation in trabecular meshwork and lamina cribrosa is the main driving force of glaucoma","volume":"15","author":"Zhavoronkov","year":"2016","journal-title":"Cell Cycle"},{"issue":"2","key":"10.1016\/j.mehy.2018.12.005_b0035","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1089\/jop.2011.0117","article-title":"Intraoperative mitomycin C versus intraoperative 5-fluorouracil for trabeculectomy: a systematic review and meta-analysis","volume":"28","author":"Lin","year":"2012","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.mehy.2018.12.005_b0040","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1167\/iovs.14-14692","article-title":"The role of the MRTF-A\/SRF pathway in ocular fibrosis","volume":"55","author":"Yu-Wai-Man","year":"2014","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.mehy.2018.12.005_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2013.02.001","article-title":"Progress in Retinal and Eye Research Molecular basis of the inner blood e retinal barrier and its breakdown in diabetic macular edema and other pathological conditions","author":"Klaassen","year":"2013","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.mehy.2018.12.005_b0050","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3109\/02713683.2012.661114","article-title":"Role of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathy","volume":"37","author":"Zhou","year":"2012","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.mehy.2018.12.005_b0055","first-page":"1","article-title":"Myo fi broblasts in proliferative diabetic retinopathy can originate from in fi ltrating fi brocytes and through endothelial-to-mesenchymal transition (EndoMT)","author":"El-asrar","year":"2015","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.mehy.2018.12.005_b0060","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000360462","article-title":"Macular diseases: epiretinal membrane","volume":"54","author":"Inoue","year":"2014","journal-title":"Dev Ophthalmol Basel, Karger"},{"key":"10.1016\/j.mehy.2018.12.005_b0065","first-page":"19","article-title":"Molecular mechanisms of subretinal fibrosis in age-related macular degeneration","author":"Ishikawa","year":"2017","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.mehy.2018.12.005_b0070","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1001\/archopht.1997.01100160043006","article-title":"Diabetic macular Edema","volume":"115","author":"Donald","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.mehy.2018.12.005_b0075","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.exer.2015.04.004","article-title":"Retinal fibrosis in diabetic retinopathy","volume":"142","author":"Roy","year":"2016","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.mehy.2018.12.005_b0080","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/bjophthalmol-2011-301005","article-title":"A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy","volume":"96","author":"Van Geest","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.mehy.2018.12.005_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2013.02.012","article-title":"Subfoveal fibrosis in eyes with neovascular age-related macular degeneration treated with intravitreal ranibizumab","volume":"156","author":"Bloch","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.mehy.2018.12.005_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2017.08.013","article-title":"Preoperative bevacizumab administration in proliferative diabetic retinopathy patients undergoing vitrectomy: a randomized and controlled trial comparing interval variation","volume":"183","author":"Castillo","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.mehy.2018.12.005_b0095","doi-asserted-by":"crossref","first-page":"26746","DOI":"10.1074\/jbc.270.45.26746","article-title":"To C1q, produced exclusively in adipocytes","author":"Scherer","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2018.12.005_b0100","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1006\/bbrc.1996.0587","article-title":"cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (Adipose Most Abundant Gene Transcript 1)","volume":"221","author":"Maeda","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.mehy.2018.12.005_b0105","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jnutbio.2009.06.003","article-title":"Adiponectin and energy homeostasis: consensus and controversy","volume":"20","author":"Dridi","year":"2009","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.mehy.2018.12.005_b0110","doi-asserted-by":"crossref","first-page":"45021","DOI":"10.1074\/jbc.M307878200","article-title":"Adiponectin stimulates production of nitric oxide in vascular endothelial cells","volume":"278","author":"Chen","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2018.12.005_b0115","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0308671100","article-title":"Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis","author":"Br\u00e5kenhielm","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2018.12.005_b0120","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.febslet.2007.04.024","article-title":"Expression of adiponectin in choroidal tissue and inhibition of laser induced choroidal neovascularization by adiponectin","volume":"581","author":"Bora","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1016\/j.mehy.2018.12.005_b0125","article-title":"Association of serum adiponectin with diabetic microvascular complications among south Indian type 2 diabetic subjects \u2014 (CURES-133)","author":"Pradeepa","year":"2014","journal-title":"Clin Biochem"},{"key":"10.1016\/j.mehy.2018.12.005_b0130","article-title":"Adiponectin as a routine clinical biomarker","author":"Kishida","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.mehy.2018.12.005_b0135","doi-asserted-by":"crossref","DOI":"10.3109\/02713683.2012.676700","article-title":"Aqueous humor and plasma adiponectin levels in proliferative diabetic retinopathy patients","author":"Mao","year":"2012","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.mehy.2018.12.005_b0140","first-page":"10","article-title":"The role of endothelial dysfunction driven by adipocitokines in the development and progression of microvascular complications in patients with type 1 and type 2 diabetes q","author":"Blaslov","year":"2015","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2018.12.005_b0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110405","article-title":"Adiponectin agonist ADP355 attenuates CCL4-induced liver fibrosis in mice","volume":"9","author":"Kumar","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mehy.2018.12.005_b0150","first-page":"1","article-title":"AdipoR1\/APPL1 potentiates the protective effects of globular adiponectin on angiotensin II-induced cardiac hypertrophy and fibrosis in neonatal rat atrial myocytes and fibroblasts","volume":"9","author":"Cao","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mehy.2018.12.005_b0155","first-page":"1","article-title":"Adiponectin attenuates lung fibroblasts activation and pulmonary fibrosis induced by paraquat","author":"Yao","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mehy.2018.12.005_b0160","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1080\/14756366.2017.1284067","article-title":"A potent peptide as adiponectin receptor 1 agonist to against fibrosis","volume":"32","author":"Ma","year":"2017","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.mehy.2018.12.005_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-04162-1","article-title":"Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target","volume":"7","author":"Marangoni","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.mehy.2018.12.005_b0170","first-page":"1","article-title":"Adiponectin promotes monocyte-to-fibroblast transition in renal fibrosis","author":"Yang","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.mehy.2018.12.005_b0175","first-page":"639","article-title":"Expression and localisation of adiponectin and its receptors in human ocular tissues","volume":"5","author":"Vidhya","year":"2014","journal-title":"Int J Pharm Bio Sci"},{"key":"10.1016\/j.mehy.2018.12.005_b0180","first-page":"993","article-title":"Measurement of adiponectin in vitreous and plasma of patients with proliferative diabetic retinopathy and its correlation with vascular endothelial growth factor and pigment epithelial derived growth factor","volume":"4","author":"Vidhya","year":"2013","journal-title":"Int J Pharm Bio Sci"},{"key":"10.1016\/j.mehy.2018.12.005_b0185","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4103\/0253-7613.150376","article-title":"Effect of adiponectin on expression of vascular endothelial growth factor and pigment epithelium-derived factor: an in vitro study","volume":"47","author":"Srinivasan","year":"2015","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.mehy.2018.12.005_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellbi.2009.04.013","article-title":"Inhibition of new vessel growth in mouse model of laser-induced choroidal neovascularization by adiponectin peptide II","author":"Lyzogubov","year":"2009","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.mehy.2018.12.005_b0195","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.exer.2014.10.016","article-title":"The role of CTGF in diabetic retinopathy","volume":"133","author":"Klaassen","year":"2015","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.mehy.2018.12.005_b0200","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.exer.2011.11.006","article-title":"Adipokine levels in subretinal fluid from patients with rhegmatogenous retinal detachment","volume":"94","author":"Ricker","year":"2012","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.mehy.2018.12.005_b0205","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/glia.22942","article-title":"M\u00fcller glia as an important source of cytokines and inflammatory factors present in the gliotic retina during proliferative vitreoretinopathy","volume":"64","author":"Eastlake","year":"2016","journal-title":"Glia"},{"key":"10.1016\/j.mehy.2018.12.005_b0210","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.4049\/jimmunol.179.8.5483","article-title":"Adiponectin enhances IL-6 production in human synovial fibroblast via an AdipoR1 receptor, AMPK, p38, and NF-\u03baB pathway","volume":"179","author":"Tang","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2018.12.005_b0215","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/03009742.2015.1025833","article-title":"The effect of multimeric adiponectin isoforms and leptin on the function of rheumatoid fibroblast-like synoviocytes","volume":"44","author":"Kontny","year":"2015","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.mehy.2018.12.005_b0220","first-page":"326","article-title":"Adiponectin and inflammation: consensus and controversy","author":"Fantuzzi","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.mehy.2018.12.005_b0225","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","article-title":"The pro- and anti-inflammatory properties of the cytokine interleukin-6","volume":"1813","author":"Scheller","year":"2011","journal-title":"Biochim Biophys Acta \u2013 Mol Cell Res"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987718305218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987718305218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T02:52:02Z","timestamp":1548557522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987718305218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":45,"alternative-id":["S0306987718305218"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2018.12.005","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adiponectin: A potential candidate for treating fibrosis in posterior segment of the eye","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2018.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}